Suppr超能文献

肺癌外科治疗的时间趋势。

Time trend in the surgical therapy of lung cancer.

作者信息

Stolz A, Pafko P, Lischke R, Harustiak T, Simonek J, Schutzner J, Adamek S

机构信息

3rd Department of Surgery, First Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic.

出版信息

Bratisl Lek Listy. 2011;112(4):174-6.

Abstract

BACKGROUND

The purpose of our study was to clarify results of surgery for non-small cell lung cancer (NSCLC) and its time trends.

METHODS

We retrospectively reviewed our prospective database of patients who underwent surgery for NSCLC between 1998 and 2009 in our institution. Patients were divided into two equal 6-year periods according to the year of surgery (1998-2003 and 2004-2009).

RESULTS

One thousand, four hundred and twelve patients underwent operation for NSCLC. We performed 985 lobectomies with 30-days mortality of 1.8 % and 300 pneumonectomies with 30-days mortality of 5.7 %. Median of survival of all 1412 patients was 4.3 year and 5-year survival was 45 %. The percentage of female patients, lobectomies and adenocarcinomas increased over time, as well as the age of our patients. Outcome improved over time, with significant decrease in a 30-days mortality after pneumonectomy (8.2 % vs 2.3 %, p=0.029). The overall 3-year survival improved in patients with stage III (30 % vs 40 %, p=0.012).

CONCLUSION

Outcomes of lung resection for NSCLC improved over time despite a worsening of some elements of preoperative status. The shift in histological distribution was associated with an increasing proportion of patients with stage I, a lower operative mortality and better 3- and 5-year survival. These trends are due to improvement of preoperative evaluation, preoperative and postoperative care (Tab. 1, Fig. 2, Ref. 9). Full Text in free PDF www.bmj.sk.

摘要

背景

我们研究的目的是阐明非小细胞肺癌(NSCLC)手术的结果及其时间趋势。

方法

我们回顾性分析了1998年至2009年在我院接受NSCLC手术患者的前瞻性数据库。根据手术年份将患者分为两个相等的6年期(1998 - 2003年和2004 - 2009年)。

结果

1412例患者接受了NSCLC手术。我们进行了985例肺叶切除术,30天死亡率为1.8%;300例全肺切除术,30天死亡率为5.7%。1412例患者的中位生存期为4.3年,5年生存率为45%。随着时间推移,女性患者、肺叶切除术和腺癌的比例增加,患者年龄也增加。结果随时间有所改善,全肺切除术后30天死亡率显著降低(8.2%对2.3%,p = 0.029)。Ⅲ期患者的总体3年生存率有所提高(30%对40%,p = 0.012)。

结论

尽管术前状况的某些因素有所恶化,但NSCLC肺切除的结果随时间有所改善。组织学分布的变化与Ⅰ期患者比例增加、手术死亡率降低以及3年和5年生存率提高有关。这些趋势归因于术前评估、术前和术后护理的改善(表1,图2,参考文献9)。全文免费PDF版见www.bmj.sk

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验